Brookview Hills Research Associates, LLC
Winston-Salem, North Carolina 27103-7108
5 studies enrolling now · 28 studies all time
What they study most
ADPKD, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Atherosclerotic Cardiovascular Disease, Autosomal Dominant Polycystic Kidney, Cardiovascular Disease, Chronic Kidney Disease, Chronic Kidney Diseases, Chronic Renal Failure, Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Diabetic Kidney Disease (DKD), Diabetic Nephropathies
Studies at this site
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease — Recruiting now
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — Recruiting now
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease — Running, not enrolling
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
- A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
- Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus — Completed
- Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus — Completed
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
- A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease — Completed
- A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease — Completed
- A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease — Completed
- Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease — Stopped early
- Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria — Completed
- Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria — Completed
- Efficacy and Safety of Atacicept in IgA Nephropathy — Stopped early
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed
- Treatment of Uremic Pruritus With PA101B — Completed
- Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus — Completed
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed